Evidence map›Paper›PMID 32685371›Full record

ArticleIDCases2020

Michael Coles, Kayla Cox, Andrew Chao

Abstract readCase Reports
In one paragraph

Article in IDCases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. An update on clinically relevant, rare, and emergingClinical microbiology reviews · 2025
    Review
  2. Trend ofCurrent medical mycology · 2025
    Article
  3. Deciphering cargo contents in extracellular vesicles ofComputational and structural biotechnology journal · 2025
    Article
  4. First report of amphotericin B resistantIranian journal of microbiology · 2024
    Article
  5. Extracellular Vesicles fromJournal of fungi (Basel, Switzerland) · 2023
    Article
  6. The Flo Adhesin Family.Pathogens (Basel, Switzerland) · 2021
    Review
  7. Insights into the Multi-Azole Resistance Profile inJournal of fungi (Basel, Switzerland) · 2020
    Article
  8. Susceptibility of theJournal of fungi (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michael ColesAugusta University, 1120 15Street, Augusta, GA, 30912, USA.
Kayla CoxAugusta University, 1120 15Street, Augusta, GA, 30912, USA.
Andrew ChaoAugusta University, 1120 15Street, Augusta, GA, 30912, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Candida species are ubiquitous fungal pathogens that exhibit increasing resistance to anti-fungal agents.

Indexed as

Candida haemuloniiDebridementDiabetesOsteomyelitisWound care

Identifiers

PMID32685371
PMCPMC7358735

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.